Insights into the effects of N-glycosylation on the characteristics of the VC1 domain of the human receptor for advanced glycation end products (RAGE) secreted by Pichia pastoris.

LC/mass spectrometry Pichia pastoris Protein glycoforms Protein-protein interactions Receptor for advanced glycation end products (RAGE) Released glycan profiling Thermal stability

Journal

Glycoconjugate journal
ISSN: 1573-4986
Titre abrégé: Glycoconj J
Pays: United States
ID NLM: 8603310

Informations de publication

Date de publication:
02 2019
Historique:
received: 10 08 2018
accepted: 18 12 2018
revised: 23 11 2018
pubmed: 7 1 2019
medline: 30 5 2019
entrez: 7 1 2019
Statut: ppublish

Résumé

Advanced glycation end products (AGEs) and advanced lipoxidation end products (ALEs), resulting from non-enzymatic modifications of proteins, are potentially harmful to human health. They directly act on proteins, affecting structure and function, or through receptor-mediated mechanisms. RAGE, a type I transmembrane glycoprotein, was identified as a receptor for AGEs. RAGE is involved in chronic inflammation, oxidative stress-based diseases and ageing. The majority of RAGE ligands bind to the VC1 domain. This domain was successfully expressed and secreted by Pichia pastoris. Out of two N-glycosylation sites, one (Asn25) was fully occupied while the other (Asn81) was under-glycosylated, generating two VC1 variants, named p36 and p34. Analysis of N-glycans and of their influence on VC1 properties were here investigated. The highly sensitive procainamide labeling method coupled to ES-MS was used for N-glycan profiling. N-glycans released from VC1 ranged from Man

Identifiants

pubmed: 30612271
doi: 10.1007/s10719-018-09855-x
pii: 10.1007/s10719-018-09855-x
doi:

Substances chimiques

Polysaccharides 0
Receptor for Advanced Glycation End Products 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-38

Références

Glycoconj J. 2016 Aug;33(4):553-68
pubmed: 27438287
Genes Immun. 2002 May;3(3):123-35
pubmed: 12070776
J Biol Chem. 1994 Apr 29;269(17):12527-35
pubmed: 8175662
Glycoconj J. 2018 Oct;35(5):443-450
pubmed: 29987432
Glycoconj J. 2016 Aug;33(4):607-17
pubmed: 27277623
PLoS One. 2016 Oct 18;11(10):e0164041
pubmed: 27755550
Diabetes Care. 1999 Apr;22(4):646
pubmed: 10189547
Methods Mol Biol. 2015;1321:103-22
pubmed: 26082218
Arthritis Rheum. 2002 Jan;46(1):114-23
pubmed: 11822407
Redox Biol. 2017 Apr;11:275-285
pubmed: 28013188
Biochem Biophys Res Commun. 2006 Aug 18;347(1):4-11
pubmed: 16806067
Protein Expr Purif. 2015 Oct;114:48-57
pubmed: 26118699
J Mol Med (Berl). 2005 Nov;83(11):876-86
pubmed: 16133426
Intern Med. 2005 May;44(5):397-8
pubmed: 15942078
J Biol Chem. 2011 Jun 17;286(24):21384-92
pubmed: 21511948
Protein Sci. 2010 Jul;19(7):1386-94
pubmed: 20506535
Biochemistry. 2008 Nov 25;47(47):12299-311
pubmed: 19032093
Science. 2006 Sep 8;313(5792):1441-3
pubmed: 16960007
Structure. 2010 Oct 13;18(10):1342-52
pubmed: 20947022
J Biol Chem. 2017 Apr 28;292(17):6978-6986
pubmed: 28298446
Glycobiology. 2018 Nov 1;28(11):825-831
pubmed: 30137320
J Biol Chem. 2008 Oct 3;283(40):27255-69
pubmed: 18667420
Cold Spring Harb Perspect Biol. 2013 Aug 01;5(8):a013359
pubmed: 23751184
J Mol Med (Berl). 2013 Dec;91(12):1369-81
pubmed: 24132651
Curr Pharm Des. 2014;20(14):2395-402
pubmed: 23844818
Biochim Biophys Acta. 2007 Oct;1770(10):1468-74
pubmed: 17714874
Mol Med. 2015 Oct 27;21 Suppl 1:S32-40
pubmed: 26605646
J Biol Chem. 2012 Jun 1;287(23):18985-94
pubmed: 22493510
Glycoconj J. 2016 Aug;33(4):645-52
pubmed: 27270766
J Biol Chem. 2000 Dec 15;275(50):39027-31
pubmed: 10976109
Biochim Biophys Acta. 1999 Jan 6;1426(2):227-37
pubmed: 9878752
Free Radic Res. 2013 Aug;47 Suppl 1:3-27
pubmed: 23767955
Carbohydr Res. 2000 Apr 20;325(3):216-21
pubmed: 10795813
Aging Cell. 2016 Jun;15(3):465-76
pubmed: 26853893
Free Radic Res. 2013 Aug;47 Suppl 1:93-137
pubmed: 23560617
J Biol Chem. 1991 Dec 5;266(34):22807-17
pubmed: 1744075
J Biol Chem. 2008 Apr 11;283(15):9724-36
pubmed: 18234669
Redox Biol. 2014 Jan 09;2:411-29
pubmed: 24624331
Biochemistry. 2007 Jun 12;46(23):6957-70
pubmed: 17508727
J Biol Chem. 2010 Dec 24;285(52):40762-70
pubmed: 20943659
Glycoconj J. 2016 Aug;33(4):691-2
pubmed: 27421862
Crit Rev Biochem Mol Biol. 1991;26(1):1-52
pubmed: 1678690
J Biol Chem. 2011 Dec 2;286(48):41736-44
pubmed: 21990362

Auteurs

Genny Degani (G)

Department of Biosciences (DBS), University of Milan, Via Celoria 26, 20133, Milan, Italy.

Alberto Barbiroli (A)

Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133, Milan, Italy.

Paula Magnelli (P)

New England Biolabs, Inc., Ipswich, MA, 01938, USA.

Stefania Digiovanni (S)

Department of Biosciences (DBS), University of Milan, Via Celoria 26, 20133, Milan, Italy.

Alessandra Altomare (A)

Department of Pharmaceutical Sciences (DISFARM), University of Milan, Via Mangiagalli 25, Milan, Italy.

Giancarlo Aldini (G)

Department of Pharmaceutical Sciences (DISFARM), University of Milan, Via Mangiagalli 25, Milan, Italy.

Laura Popolo (L)

Department of Biosciences (DBS), University of Milan, Via Celoria 26, 20133, Milan, Italy. laura.popolo@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH